What is the impact of this medicine on neutrophil, platelet, and red blood cell levels?
Brukinsa (Zanubrutinib)
Status:
Open Aug 14, 2025 - 12:11 PM
1answer
Answer
Aug 14, 2025 - 12:11 PM
The medicine may cause dangerously low levels of neutrophils, platelets, and red blood cells, requiring regular blood tests and possible adjustments in treatment. Monitoring blood counts helps in managing and mitigating the risks of low blood cell levels.
View More Product Details
Brukinsa (Zanubrutinib)
Manage mantle cell lymphoma with Brukinsa. Buy Brukinsa online from Canada Pharmacy and save on your medication. Order now for improved cancer care!
View Details
View all Brukinsa (Zanubrutinib) Questions & Answers
